Beheshti M, Manafi-Farid R, Geinitz H, et al. - A prospective study was conducted to ascertain the effect of the multiphasic acquisition of ⁶⁸Ga-PSMA PET/CT in the detection of recurrent prostate cancer in the early stage of biochemical recurrence with a prostate-specific antigen (PSA) level of less than 1 ng/mL. Researchers performed a prospective monocentric study on 135 prostate cancer patients with biochemical recurrence and a PSA level of less than 1 ng/mL. The results exhibited that in patients with a PSA level of 0.5–1.0 ng/mL, ⁶⁸Ga-PSMA PET/CT showed promise for early detection of recurrent disease. Nevertheless, it displayed limited value in patients with a PSA level of less than 0.5 ng/mL. It was reported that multiphasic ⁶⁸Ga-PSMA PET/CT led to a better determination of equivocal findings. Delayed acquisitions seem to have a greater impact on clarifying equivocal findings, although dynamic images may provide helpful information for the assessment of the prostate bed.